Contents
Download PDF
pdf Download XML
311 Views
94 Downloads
Share this article
Case Report | Volume 13 Issue:4 (, 2023) | Pages 481 - 484
Case of Essential Thrombocytosis Presenting with Proximal Aortic Thrombosis and Spinal Cord ischemia
Under a Creative Commons license
Open Access
Received
Aug. 20, 2023
Revised
Sept. 18, 2023
Accepted
Oct. 1, 2023
Published
Oct. 20, 2023
Abstract

Background: Essential Thrombocytosis is a clonal hematopoietic stem cell disorder that causes increased platelet production. Patients are at risk of microvascular thrombosis and hemorrhage. Essential Thrombocytosis is a diagnosis of exclusion. We reported a case of Essential Thrombocytosis in 42 years female, where initial platelet count of 17 lakhs was reduced to post procedure count of 7.6 lakhs. Treatment consists of aspirin, platelet-lowering drugs (e.g., hydroxyurea, interferon, anagrelide), plateletpheresis, cytotoxic agents & rarely stem cell transplantation. The most important first step in the management of ET is to confirm the accuracy of the diagnosis and make sure that other myeloid neoplasms, which might mimic Essential Thrombocytosis in their presentation are excluded.

Keywords
Recommended Articles
Research Article
Study The Effects of Dexmedetomidine on Postoperative Nausea and Vomiting. And Adverse Effects Like Bradycardia and Hypotension In Patients Undergoing Laparoscopic Surgeries
...
Published: 30/01/2025
Download PDF
Research Article
Study the hemodynamic parameters of Dexmedetomidine and Tramadol
...
Published: 30/09/2025
Download PDF
Research Article
Compare The Postoperative Analgesia and Adverse Effects of Bupivacaine in Comparison to Bupivacaine and Nalbuphine Combination During Spinal Anesthesia in Lower Abdominal Surgeries
...
Published: 30/09/2025
Download PDF
Research Article
Study the efficacy of dexmedetomidine for attenuation of hemodynamic responses in patients undergoing laparoscopic surgeries
...
Published: 30/12/2024
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.